Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08JYV
|
||||
Former ID |
DIB016269
|
||||
Drug Name |
PSMA subunit vaccine
|
||||
Synonyms |
Recombinant soluble PSMA vaccine; RsPSMA vaccine; PSMA subunit vaccine (prostate cancer); PSMA recombinant soluble protein vaccine, CYTOGEN/Progenics; PSMA rs protein vaccine, CYTOGEN/Progenics; PSMA protein vaccine (prostate cancer), Progenics/CYTOGEN; PSMA purified protein vaccine (prostate cancer), Progenics/CYTOGEN; PSMA subunit vaccine (prostate cancer), Progenics/CYTOGEN; PSMA-based therapeutics, CYTOGEN/Progenics
|
||||
Drug Type |
Vaccine
|
||||
Indication | Prostate cancer [ICD9: 185; ICD10:C61] | Phase 1 | [550234] | ||
Company |
Alphavax
|
||||
Target and Pathway | |||||
Target(s) | Glutamate carboxypeptidase II | Target Info | [543445] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
TNFalpha Signaling Pathway | |||||
WikiPathways | One Carbon Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.